News

Verywell Health on MSN12h
Not Enough Adults Are Getting the RSV Vaccine. Here's Why That Matters
“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...
GSK seeks FDA nod for expanded use of RSV vaccine in adults
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...
HealthDay on MSN4d
CDC Now Recommends RSV Vaccine for Some Adults Aged 50 Years and Older
The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...
Stocktwits on MSN1d
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance
GSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine ...
Pharmaceutical Technology on MSN1d
GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients
The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...
RSV vaccine access expanded to some people in their 50s, according to CDC website
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...